TOMI Environmental Solutions (OTC: TOMZ) is a disinfection and decontamination company that develops and sells hydrogen peroxide-based fogging systems and consumable solutions for indoor air and surface treatment. Revenue comes from four streams: equipment sales, BIT Solution consumables, corporate decontamination services, and Installation/Operational/Performance Qualification (IOP/Q) services. The company operates across four divisions: Life Sciences, Hospital-Healthcare, Food Safety, and Commercial. Its flagship SteraMist product line uses patented Binary Ionization Technology, originally developed under a DARPA grant, to generate ionized hydrogen peroxide that achieves a 6-log kill rate against pathogens. Total revenue was $5.6 million for the year ended December 31, 2025, down 27% from $7.7 million in FY2024. The company carries an accumulated deficit of $58.1 million as of December 31, 2025, held approximately $88,000 in cash at that date, and its auditors have issued a going concern qualification. SteraMist is deployed in over 40 countries and protected by more than 30 utility and design patents through 2038.
- Revenue model
- Transactional and recurring revenue mix: equipment sales (one-time hardware purchases), BIT Solution consumables sold on a recurring basis consistent with a razor-blade model, corporate decontamination service engagements, and IOP/Q validation services. OEM partnerships with PBSC, ESCO, Steelco, Nuaire, and Getinge embed iHP technology at the point of manufacture, extending distribution without proportional direct sales cost.
- Products and services
- SteraMist product line includes: handheld Surface Unit (portable, quick-turnover disinfection), Environment System (ENV, fourth-generation, remotely controlled room disinfection for spaces up to 103.8 m³), all-in-one backpack system (cordless, AC/DC compatible), and Total Disinfection Cart. BIT Solution is a 7.8% hydrogen peroxide consumable sold in 32-oz bottles and gallon formats. Integrated systems include the SIS iHP Passthrough and Hybrid and CES offerings for cleanroom and biosafety cabinet integration. A heart monitoring medical device utilizing the iHP platform is nearing Factory Acceptance Testing as of the FY2025 10-K filing date.
- Customers and end markets
- Life Sciences customers include Pfizer, Merck, AbbVie, Bausch & Lomb, ThermoFisher Scientific, Eli Lilly, FUJIFILM Diosynth Biotechnologies USA, and Fresenius Kabi. Government customers include NIH, USDA, CDC, USAMRIID, USAMRICD, and NASA Johnson Space Center. Food safety customers include Nestle, Sensient Technologies, Mayorga Organics, Lakeview Farms, Batory Foods, Danone, and Perdue. Healthcare customers include Tower Health, Novant Health, Corewell Health, St. Jude Children's Research Hospital, and Mass General Brigham. Commercial customers include T.A.C.T. franchises (purchased $175,000 of equipment and BIT Solution in Q4 FY2025) and Steri-Clean (approximately 60 locations). End markets span life sciences, hospital-healthcare, food safety, commercial, aerospace (NASA deployment Q1 FY2025), and cell and gene therapy.
- Value-chain role
- Product developer, manufacturer (via third-party suppliers), and direct service provider. Sells through direct sales, independent representatives, and a global distributor and certified service provider network operating under the SteraMist brand. OEM partnerships embed iHP technology into third-party cleanroom and biosafety equipment at point of manufacture.
- Geographic exposure
- Domestic and international revenue both reported for FY2025; domestic declined primarily from lower equipment sales while international remained relatively stable, with sales into Canada, the UK, and Europe. Products carry EPA registration in all 50 U.S. states, Washington D.C., Canada, and approximately 40 other countries. SteraMist deployed in over 40 countries as of the FY2025 10-K.
